↓ Skip to main content

The HSP90 inhibitor ganetespib has chemosensitizer and radiosensitizer activity in colorectal cancer

Overview of attention for article published in Investigational New Drugs, April 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (77th percentile)
  • Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

patent
5 patents

Citations

dimensions_citation
63 Dimensions

Readers on

mendeley
42 Mendeley
Title
The HSP90 inhibitor ganetespib has chemosensitizer and radiosensitizer activity in colorectal cancer
Published in
Investigational New Drugs, April 2014
DOI 10.1007/s10637-014-0095-4
Pubmed ID
Authors

Suqin He, Donald L. Smith, Manuel Sequeira, Jim Sang, Richard C. Bates, David A. Proia

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 42 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 42 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 10 24%
Student > Bachelor 8 19%
Researcher 6 14%
Student > Master 6 14%
Student > Doctoral Student 3 7%
Other 5 12%
Unknown 4 10%
Readers by discipline Count As %
Medicine and Dentistry 12 29%
Agricultural and Biological Sciences 10 24%
Biochemistry, Genetics and Molecular Biology 6 14%
Pharmacology, Toxicology and Pharmaceutical Science 2 5%
Engineering 2 5%
Other 5 12%
Unknown 5 12%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 December 2019.
All research outputs
#4,770,911
of 23,079,238 outputs
Outputs from Investigational New Drugs
#166
of 1,175 outputs
Outputs of similar age
#47,482
of 226,940 outputs
Outputs of similar age from Investigational New Drugs
#4
of 16 outputs
Altmetric has tracked 23,079,238 research outputs across all sources so far. Compared to these this one has done well and is in the 76th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,175 research outputs from this source. They receive a mean Attention Score of 4.7. This one has done well, scoring higher than 79% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 226,940 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 77% of its contemporaries.
We're also able to compare this research output to 16 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 75% of its contemporaries.